A recent retrospective observational study examined adults with type 2 diabetes treated with GLP-1 receptor agonists and found important nutritional and body composition concerns alongside weight loss.

"Over 20 % had nutritional deficiencies diagnosed within one-year of starting GLP-1RA treatment."

Key points

• Use of GLP-1 receptor agonists was associated with loss of lean muscle mass, not just fat mass.

In this head-to-head trial, mazdutide outperformed dulaglutide on both glycemic control and weight reduction in adults with type 2 diabetes over 28 weeks, with a safety profile similar to other GLP-based therapies.

pubmed.ncbi.nlm.nih.gov

Mazdutide is a once-weekly glucagon and glucagon-like peptide-1 receptor dual agonist developed for the treatment of type 2 diabetes (T2D) ¹. This study assessed the efficacy and safety of mazdutide versus dulaglutide in participants with T2D on background oral anti-diabetic drugs. In thi …

Ethnic minorities in England less likely to have access to diabetes tech. The Guardian covered a new study published in Diabetic Medicine demonstrating that people from ethnic minority groups in England face significantly lower rates of continuous glucose monitor (CGM) prescribing despite higher type 2 diabetes risk. This health services research points to structural inequities that could affect outcomes even when effective tools exist.

www.theguardian.com

‘Concerning’ disparities in access to continuous glucose monitors despite black and south Asian people being more likely to live with condition

Diabetes drugs may be changing cancer in surprising ways – new findings show that medications commonly used in type 2 diabetes not only impact glucose and weight control but might also influence cancer risk. Researchers are examining how these therapies might either reduce or inadvertently affect risks for multiple cancer types (e.g., liver, colorectal, breast), pointing to mechanisms beyond traditional metabolic control.

https://www.sciencedaily.com/releases/2025/12/251226045322.htm

Artificial intelligence is transforming food safety and nutrition by enabling scalable, real-time, and personalized solutions.

In food safety, AI supports predictive risk modeling, contaminant detection, smart surveillance, and food traceability. In nutrition, it enables personalized diet recommendations, automated dietary tracking, and virtual nutrition coaching. At the same time, AI raises concerns related to data bias, transparency, privacy, regulation, and equitable access.

This review explores current applications, key challenges, and considerations for responsibly integrating AI into food systems in ways that align with public health priorities.

https://www.academia.edu/3067-1345/2/3/10.20935/AcadNutr7904

Family Caregivers of British Columbia (FCBC) is a provincial, not-for-profit organization that supports over one million caregivers in the province by providing information, education, emotional support, and access to resources. Caregivers can access one-on-one support, support groups, health system navigation, and free educational materials, and can reach the B.C. Caregiver Support Line at 1-877-520-3267 for assistance.

www.familycaregiversbc.ca

Supporting unpaid caregivers with tools, connection and education so you can show up strongly for yourself and those you care for.

https://www.census.gc.ca/en/index

Tired of searching for healthy recipes?

Diabetes UK's Recipe Finder has over 500 delicious meals, snacks, and desserts, all checked and approved by a specialist team of dietitians! Filter by low sugar, low fat, vegan, and more.

Eat well with confidence!

https://www.diabetes.org.uk/living-with-diabetes/eating/recipes